Internal Medicine, Rheumatology · Stanford, CA
NPI
1548326606
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
5,234 services
Medicare patients, 2024
361
Average age 76
Drug cost, 2024
$2.5M
1,996 prescriptions
Company payments, 2025
$221
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew L Rozelle was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 391 times for 250 patients. In total Andrew L Rozelle billed 5,234 services in 30 codes, and Medicare paid $122K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 391 | 250 | $14.39 | $5,625 |
| 99215 Office E&M - Established | Office | 341 | 217 | $150.28 | $51K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 271 | 49 | $0.75 | $202 |
| 99214 Office E&M - Established | Office | 127 | 105 | $104.65 | $13K |
| 99213 Office E&M - Established | Office | 84 | 75 | $85.75 | $7,203 |
| 99205 Office E&M - New | Office | 69 | 69 | $197.53 | $14K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 51 | 41 | $29.59 | $1,509 |
| 20610 Joint Injection | Office | 44 | 28 | $61.09 | $2,688 |
| 20600 Joint Injection | Office | 25 | 16 | $43.32 | $1,083 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $38.29 | $498 |
| 90662 Vaccine Product | Office | 12 | 12 | $81.82 | $982 |
By year: 2022 $192K for 18,760 services; 2023 $167K for 14,989 services; 2024 $122K for 5,234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew L Rozelle prescribed most often to Medicare patients was Prednisone, with 284 prescriptions and refills. In total Andrew L Rozelle wrote 1,996 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 284 | 444 | 66 | $3,047 |
| Methotrexate Methotrexate Sodium | 268 | 655 | 84 | $9,528 |
| Allopurinol Generic | 173 | 486 | 51 | $2,284 |
| Hydroxychloroquine Sulfate Generic | 131 | 267 | 38 | $3,750 |
| Alendronate Sodium Generic | 80 | 190 | 23 | $800 |
| Humira(Cf) Pen Adalimumab | 63 | 63 | Under 11 | $428K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 55 | 55 | Under 11 | $967 |
| Enbrel Sureclick Etanercept | 54 | 54 | Under 11 | $395K |
| Folic Acid Generic | 53 | 155 | 18 | $731 |
| Xeljanz Xr Tofacitinib Citrate | 44 | 56 | Under 11 | $324K |
| Celecoxib Generic | 43 | 73 | 14 | $2,418 |
| Duloxetine Hcl Generic | 40 | 97 | Under 11 | $1,026 |
| Leucovorin Calcium Generic | 38 | 82 | Under 11 | $1,057 |
| Omeprazole Generic | 36 | 106 | 14 | $467 |
| Orencia Clickject Abatacept | 36 | 36 | Under 11 | $202K |
Brand drugs: - claims; generic drugs: 1,562 claims; opioid claims: 97.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew L Rozelle $221 ($221 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $207.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.